Matrix Metalloproteinases in AtherothrombosisBÄCK, Magnus; KETELHUTH, Daniel F. J; AGEWALL, Stefan et al.Progress in cardiovascular diseases. 2010, Vol 52, Num 5, pp 410-428, issn 0033-0620, 19 p.Article

Cellular immunity, low-density lipoprotein and atherosclerosis: Break of tolerance in the artery wall : Immunology of atherosclerosisKETELHUTH, Daniel F. J; HANSSON, Göran K.Thrombosis and haemostasis. 2011, Vol 106, Num 5, pp 779-786, issn 0340-6245, 8 p.Article

T Cell-based Therapies for Atherosclerosis : Novel Targets and Biomarkers for Anti-atherosclerotic TherapyKETELHUTH, Daniel F. J; GISTERA, Anton; JOHANSSON, Daniel K et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 33, pp 5850-5858, issn 1381-6128, 9 p.Article

Identification of a Danger-Associated Peptide From Apolipoprotein B100 (ApoBDS-1) That Triggers Innate Proatherogenic ResponsesKETELHUTH, Daniel F. J; RIOS, Francisco J. O; YAN, Zhong-Qun et al.Circulation (New York, N.Y.). 2011, Vol 124, Num 22, pp 2433-2443, issn 0009-7322, 11 p.Article

Immunotherapy With Tolerogenic Apolipoprotein B-100―Loaded Dendritic Cells Attenuates Atherosclerosis in Hypercholesterolemic MiceHERMANSSON, Andreas; JOHANSSON, Daniel K; KETELHUTH, Daniel F. J et al.Circulation (New York, N.Y.). 2011, Vol 123, Num 10, pp 1083-1091, issn 0009-7322, 9 p.Article

Apolipoprotein B100 danger-associated signal 1 (ApoBDS-1) triggers platelet activation and boosts platelet-leukocyte proinflammatory responsesASSINGER, Alice; YAJUAN WANG; BUTLER, Lynn M et al.Thrombosis and haemostasis. 2014, Vol 112, Num 2, pp 332-341, issn 0340-6245, 10 p.Article

The tryptophan metabolite 3-hydroxyanthranilic acid lowers plasma lipids and decreases atherosclerosis in hypercholesterolaemic miceLEI ZHANG; OVCHINNIKOVA, Olga; JONSSON, Andreas et al.European heart journal. 2012, Vol 33, Num 16, pp 2025-2034, issn 0195-668X, 10 p.Article